Skip to main content
Clinical Trials/NCT04774848
NCT04774848
Recruiting
Not Applicable

High Frequency Oscillatory Ventilation Versus High Frequency Jet Ventilation as Initial Mode of Ventilation for Congenital Diaphragmatic Hernia

University of Utah2 sites in 1 country50 target enrollmentDecember 30, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Diaphragmatic Hernia
Sponsor
University of Utah
Enrollment
50
Locations
2
Primary Endpoint
Oxygenation Index (OI) at 24 hours of age
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to conduct a prospective study of all congenital diaphragmatic hernia (CDH) neonates managed at the University of Utah newborn intensive care unit (NICU) and Primary Children's Hospital NICU that required mechanical ventilation at birth. As both high frequency jet ventilation (HFJV) and high frequency oscillatory ventilation (HFOV) are standard approaches to ventilatory support of all neonates including CDH, CDH infants will be randomized at the time of birth or admission to either HFJV or HFOV as initial ventilator mode, stratified by position of the liver in the abdomen or thorax (if known) by 24 hours of age. Measures of oxygenation, ventilation and hemodynamics of the CDH cohort managed on HFOV compared to those on HFJV.

Registry
clinicaltrials.gov
Start Date
December 30, 2020
End Date
August 28, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michelle Yang

Principal Investigator

University of Utah

Eligibility Criteria

Inclusion Criteria

  • Admitted to either the University of Utah and/or Primary Children's Hospital NICU within 24 hours of birth
  • Requiring mechanical ventilation
  • Umbilical arterial line or peripheral arterial line in place
  • Obtained signed consent
  • Infant is ≤ 24 hours of age

Exclusion Criteria

  • Severe anomaly
  • Chromosomal abnormalities
  • Major congenital anomalies, including cardiac, central nervous system and syndromes
  • Post-natal diagnosis \> 24 hours of life
  • Unable to obtain consent for participation
  • Unable to randomize within 24 hours of life

Outcomes

Primary Outcomes

Oxygenation Index (OI) at 24 hours of age

Time Frame: 24 hours of age

The OI will be measured at 24 hours of age using a standard of care arterial blood gas and oxygen settings. These measurements will then be compared between the stratified groups

Secondary Outcomes

  • PF ratio (PaO2/FiO2) measurements(up to one week)
  • PF-PCO2 (PaO2/FiO2-PaCO2) measurements(up to one week)
  • Number of babies who received inhaled nitric oxide (iNO)(up to one week)
  • PaCO2 measurements(up to one week)

Study Sites (2)

Loading locations...

Similar Trials